The company’s shares are currently commanding a grey market premium (GMP) of around 17%, indicating expectations of a healthy listing gain, although GMP is an unofficial market indicator and should not be considered a guarantee of listing performance.
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.